| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/27/2009 | US20090214627 Methods of modifying insulin signaling using biliverdin reductase |
| 08/27/2009 | US20090214626 Platinum Complexes For Targeted Drug Delivery |
| 08/27/2009 | US20090214625 Drug delivery patch |
| 08/27/2009 | US20090214624 Topical nitric oxide donor devices and methods for their therapeutic use |
| 08/27/2009 | US20090214623 Anisotropic hydrogels |
| 08/27/2009 | US20090214622 Nanoporous Membrane and Method of Preparation Thereof |
| 08/27/2009 | US20090214621 Electrostatic Patch For Allergen Screening And Applicator For Same |
| 08/27/2009 | US20090214618 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 08/27/2009 | US20090214617 Immobilisation and stabilisation of virus |
| 08/27/2009 | US20090214616 Biomaterials having nanoscale layers and coatings |
| 08/27/2009 | US20090214614 Method for Cell Implantation |
| 08/27/2009 | US20090214613 Endothelized Artificial Matrix Comprising a Fibrin Gel, Which Is a Superproducer of Proangiogenic Factors |
| 08/27/2009 | US20090214612 Extracellular tnf inhibitors for treating cns disorders |
| 08/27/2009 | US20090214611 Implant Filling Material and Method |
| 08/27/2009 | US20090214605 Hydrophilic Core Polymeric Micelles for the Delivery of Water-Soluble Compounds |
| 08/27/2009 | US20090214603 Synthetic peptides |
| 08/27/2009 | US20090214602 Oral dosage forms including an antiplatelet agent and an enterically coated acid inhibitor |
| 08/27/2009 | US20090214601 Porous Drug Delivery Devices and Related Methods |
| 08/27/2009 | US20090214600 Methods and compositions for gastric resistant oral formulations for intestinal delivery |
| 08/27/2009 | US20090214599 Proton pump inhibitor formulations, and methods of preparing and using such formulations |
| 08/27/2009 | US20090214473 Combination chaperonin 10 and beta-interferon therapy for multiple sclerosis |
| 08/27/2009 | US20090214470 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 08/27/2009 | US20090214448 Structures and Compositions Increasing The Stability of Peroxide Actives |
| 08/27/2009 | US20090214445 Delivery systems for managing release of functional ingredients in an edible composition |
| 08/27/2009 | US20090214444 Poly aromatic sodium channel blockers |
| 08/27/2009 | US20090214443 Method for retarding systemic delivery rate for easily absorbable active agents |
| 08/27/2009 | US20090214442 Oral Transmucosal Nicotine Dosage Form |
| 08/27/2009 | US20090214427 Novel peptides |
| 08/27/2009 | DE202008017304U1 Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren Oral disintegrating film for the therapeutic use of antiparasitic agents in animals |
| 08/27/2009 | DE102008009646A1 Drug carrier system, useful e.g. for placement through urethra to bladder, comprises active ingredient and carrier material, where carrier material is able to release ingredient on long-term basis within the bladder |
| 08/27/2009 | DE102004049740B4 Selbstklebende Zahnfolie und Verfahren zur Herstellung der Zahnfolie Self-adhesive dental film and process for producing the dental film |
| 08/27/2009 | CA2715760A1 Solid preparation for oral administration |
| 08/27/2009 | CA2715665A1 Microparticle and pharmaceutical composition thereof |
| 08/27/2009 | CA2715638A1 Cardioplegia solution for cardiac surgery |
| 08/27/2009 | CA2715634A1 Blood substitute solution |
| 08/27/2009 | CA2715626A1 Sustained release poloxamer containing pharmaceutical compositions |
| 08/27/2009 | CA2714429A1 Nanoparticle carriers for drug administration and process for producing same |
| 08/27/2009 | CA2713555A1 Topical compositions and methods for whitening skin |
| 08/27/2009 | CA2713548A1 Dip coated compositions containing a starch having a high amylose content |
| 08/26/2009 | EP2093248A1 Method for removing organic solvent |
| 08/26/2009 | EP2092941A2 Drug releasing coatings for medical devices |
| 08/26/2009 | EP2092936A2 Tamper-resistant oral opioid agonist formulations |
| 08/26/2009 | EP2092935A1 Pharmaceutical compositions for the treatment of asthma |
| 08/26/2009 | EP2092913A1 Implantable stent prothesis |
| 08/26/2009 | EP2092834A1 Methods and compositions of sphingolipid for preventing treating microbial infections |
| 08/26/2009 | EP2091543A1 Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonate |
| 08/26/2009 | EP2091541A1 Vaginal delivery system for mirtazapine |
| 08/26/2009 | EP2091520A1 Oral dosage form comprising tri-substituted glycerol compounds |
| 08/26/2009 | EP2091519A1 Multiparticulates of spray-coated drug and polymer on a meltable core |
| 08/26/2009 | EP2091518A1 Method for mixing powders |
| 08/26/2009 | EP2091517A2 Materials and methods of introducing genetic material into living cells |
| 08/26/2009 | EP2091515A2 Modified release analgesic suspensions |
| 08/26/2009 | EP2091514A2 Water insoluble polymer matrix for drug delivery |
| 08/26/2009 | EP2091513A2 Ejection liquid and ejection method |
| 08/26/2009 | EP1996640B1 Microparticles comprising a crosslinked polymer |
| 08/26/2009 | EP1959932B1 Preparation of powders containing colloidal particles |
| 08/26/2009 | EP1744732A4 Nutritional composition for increasing creatine uptake in skeletal muscle |
| 08/26/2009 | EP1732525B1 Amorolfine patch for treating onychomycosis |
| 08/26/2009 | EP1592408B1 Sustained release device and method for ocular delivery of adrenergic agents |
| 08/26/2009 | EP1536840B1 Formulation for inwardly transferring nucleic acids into eucaryotic cells |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1389096B9 Delivery of opioids through an inhalation route |
| 08/26/2009 | EP1389089B1 Method and composition for solubilising a biologically active compound with low water solubility |
| 08/26/2009 | EP1379698B1 Mobility-modified nucleobase polymers and methods of using same |
| 08/26/2009 | EP1368057B1 Method to enhance the immunogenicity of an antigen |
| 08/26/2009 | EP1345587B1 Ionophore antibiotic formulations |
| 08/26/2009 | EP1330266B2 Method for making very fine particles consisting of a principle inserted in a host molecule |
| 08/26/2009 | CN201295395Y Breast block dissipating black plaster |
| 08/26/2009 | CN101516403A Orally disintegrating tablet and process for production thereof |
| 08/26/2009 | CN101516402A Gel type enteric nutrient |
| 08/26/2009 | CN101516387A Caspofungin formulations |
| 08/26/2009 | CN101516367A Solid pharmaceutical composition for optically stable ramosetron |
| 08/26/2009 | CN101516357A Emulsions comprising rubber arabicum |
| 08/26/2009 | CN101516356A Metoprolol succinate e.r. tablets and methods for their preparation |
| 08/26/2009 | CN101516355A Pharmaceutical composition comprising a plurality of mini-tablets comprising a factor Xa inhibitor |
| 08/26/2009 | CN101516354A Multi-core solid dosage form comprising a transparent coating between said cores |
| 08/26/2009 | CN101516353A Controlled release oral dosage formulations comprising a core and one or more barrier layers |
| 08/26/2009 | CN101516352A Controlled release solid oral dosage formulations comprising nisoldipine |
| 08/26/2009 | CN101516351A Extended release solid pharmaceutical composition containing carbidopa and levodopa |
| 08/26/2009 | CN101516350A Disposable infusion device with automatic unlocking mechanism |
| 08/26/2009 | CN101516349A Pharmaceutical compositions containing rosuvastatin calcium |
| 08/26/2009 | CN101516348A Solid preparation comprising ibuprofen and tranexamic acid |
| 08/26/2009 | CN101516347A Pharmaceutical formulation comprising metformin and repaglinide |
| 08/26/2009 | CN101516346A Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof |
| 08/26/2009 | CN101516345A Pharmaceutical compositions comprising an S1P modulator |
| 08/26/2009 | CN101516344A Pharmaceutical compositions comprising nilotinib or its salt |
| 08/26/2009 | CN101516343A Process for preparing granules of hydrophilic vitamins |
| 08/26/2009 | CN101516342A Processes for preparing pharmaceutical compositions |
| 08/26/2009 | CN101516341A Preparation of pharmaceutical compositions |
| 08/26/2009 | CN101516340A Preparation of pharmaceutical formulations |
| 08/26/2009 | CN101516339A Method for making solid dispersions of highly crystalline therapeutic compounds |
| 08/26/2009 | CN101516338A A pharmaceutical composition for oral comprising fenofibrate and preparation method thereof |
| 08/26/2009 | CN101516337A Preparation of glassified biological reagents |
| 08/26/2009 | CN101516336A Lysine-based polymeric linkers |
| 08/26/2009 | CN101516335A Formulations for benzimidazolyl pyridyl ethers |
| 08/26/2009 | CN101516334A Stabilizing compositions for antibiotics and methods of use |
| 08/26/2009 | CN101516333A Aqueous dronabinol formulations |
| 08/26/2009 | CN101516332A Self preserved aqueous pharmaceutical compositions |
| 08/26/2009 | CN101516331A Edible water-soluble film containing a foam reducing flavoring agent |
| 08/26/2009 | CN101516330A Methods and compositions for the treatment and prevention of infections |